CNS Pharmaceuticals, Inc. (CNSP)
4.97
+0.22
(+4.63%)
USD |
NASDAQ |
Oct 23, 16:00
4.97
0.00 (0.00%)
After-Hours: 20:00
CNS Pharmaceuticals Market Cap : 7.263M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 7.263M |
| October 22, 2026 | 6.942M |
| October 21, 2026 | 7.051M |
| October 20, 2026 | 7.292M |
| October 19, 2026 | 7.292M |
| October 16, 2026 | 7.089M |
| October 15, 2026 | 7.566M |
| October 14, 2026 | 7.818M |
| October 13, 2026 | 7.818M |
| October 12, 2026 | 7.585M |
| October 09, 2026 | 7.818M |
| October 08, 2026 | 7.818M |
| October 07, 2026 | 7.935M |
| October 06, 2026 | 7.748M |
| October 05, 2026 | 7.745M |
| October 02, 2026 | 7.782M |
| October 01, 2026 | 7.658M |
| September 30, 2026 | 7.745M |
| September 29, 2026 | 7.172M |
| September 28, 2026 | 7.468M |
| September 25, 2026 | 7.206M |
| September 24, 2026 | 7.526M |
| September 23, 2026 | 7.526M |
| September 22, 2026 | 7.657M |
| September 21, 2026 | 7.626M |
| Date | Value |
|---|---|
| September 18, 2026 | 7.468M |
| September 17, 2026 | 7.482M |
| September 16, 2026 | 8.038M |
| September 15, 2026 | 8.33M |
| September 14, 2026 | 8.33M |
| September 11, 2026 | 8.535M |
| September 10, 2026 | 8.403M |
| September 09, 2026 | 8.447M |
| September 08, 2026 | 8.681M |
| September 04, 2026 | 8.374M |
| September 03, 2026 | 8.603M |
| September 02, 2026 | 8.783M |
| September 01, 2026 | 8.611M |
| August 31, 2026 | 8.739M |
| August 28, 2026 | 8.071M |
| August 27, 2026 | 8.063M |
| August 26, 2026 | 7.95M |
| August 25, 2026 | 8.476M |
| August 24, 2026 | 8.681M |
| August 21, 2026 | 8.52M |
| August 20, 2026 | 8.768M |
| August 19, 2026 | 8.52M |
| August 18, 2026 | 8.566M |
| August 17, 2026 | 7.892M |
| August 14, 2026 | 8.067M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.668B |
| Corcept Therapeutics, Inc. | 9.266B |
| Veru, Inc. | 38.19M |
| Johnson & Johnson | 635.02B |
| Eli Lilly & Co. | 1.199T |
Market Cap Related Metrics
| Price to Book Value | 0.3991 |
| Price | 4.97 |
| Earnings Yield | -474.7% |